BofA analyst Lawson Winder’s top picks in the silver mining sector are both headquartered in Vancouver,
“BofA remains bullish on precious metals, including silver, despite the already notable strength year-to-date. As per BofA Metal Strategist, Michael Widmer, gold and silver are among our most preferred commodities, with the yellow metal pushed up by central banks, China investors and, increasingly, Western buyers on a confluence of macro factors, including an end to hiking cycles. Accordingly, we see the yellow metal rallying to $3,000 per ounce by 2025E .
The stocks selected are AbbVie Inc., Amgen Inc., Cooper Companies Inc., Charles River Laboratories International Inc., Exelixis Inc., Gilead Sciences Inc., Globus Medical Inc Class A Hologic Inc., Jazz Pharmaceuticals Public Limited Company, Johnson & Johnson, Eli Lilly and Company, Medtronic PLC, Merck 8 Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Thermo Fisher Scientific Inc. and UnitedHealth Group Incorporated.